VCANBIO CELL & GENE ENGINEERING financial statements, including revenue, expenses, profit, and loss

The total revenue of 600645 for the last quarter is 393.10 M CNY, and it's 2.49% higher compared to the previous quarter. The net income of Q1 24 is 40.15 M CNY.